Blastocystis sp. puesta al día sobre su papel parasitario: Actualización sobre Blastocystis sp.

Gilberto Bastidas; Carlos Malave; Daniel Bastidas

Autores/as

Gilberto Bastidas Doctor en Parasitología, Departamento de Salud Pública y Centro de Investigaciones Médicas y Biotecnológicas, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela.
Carlos Malave Licenciado en Ciencias Naturales, Departamento de Ciencias Pedagógicas, Facultad de Educación Universidad de Carabobo, Venezuela.
Daniel Bastidas Estudiante universitario carrera de Medicina. Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela.

Resumen

Blatocystis sp. un parásito unicelular, anaerobio y de gran variabilidad genética del intestino de animal y del ser humano de distribución mundial y el de mayor prevalencia entre las zoonosis intestinales que ha estado inmerso en controversias y revisiones por su taxonomía, características morfológicas, ciclo de vida y papel patógeno. Por tanto, el objetivo del presente escrito es la consolidación de información sobre estos y otros aspectos de Blatocystis sp. producto de la revisión de la literatura científica. Se trata de un estudio documental. Los datos encontrados fueron agrupados en 8 capítulos a saber: tipificación, comportamiento epidemiológico, ciclo de vida y morfología parasitaria, patogenia, manifestaciones clínicas, diagnóstico, tratamiento y reflexiones finales. En esta revisión se actualizan aspectos relativos a Blatocystis sp. con el objeto de mostrar las tendencias del conocimiento sobre esta parasitosis como base esencial de las estrategias de promoción y prevención que adoptan los países contra Blatocystis sp.

Métricas

Cargando métricas ...

Citas

Kozubsky L, Archelli S. Algunas consideraciones acerca de Blastocystis sp., un parásitocontroversial. Acta Bioquím Clín Latinoam 2010; 44(3):371-376.

Silberman J, Sogin M, Leipe, Clark C. Human parasite finds taxonomic home. Nature 1996; 380(6573):398.

Chacón N, Durán C, De la Parte M. Blastocystis sp. en humanos: actualización y experiencia clínico-terapéutica. Bol Venez Infectol 2017; 28(1):5-14.

Brumpt E. Colite a Tetramitus mesnili (Wenyon 1910) et colite a Trichomonas intestinalis Leuchart 1879. Blastocystis hominis n sp et formes voisines Bull Socww Pathol Exot 1912; 5:725-730.

Alexeieff A. Sur la nature des formations dites “kystes de Trichomonas intestinalis.” C R Soc Biol 1911; 71:296-298.

Zierdt CH, Rude W, Bull B. Protozoan characteristics of Blastocystis hominis Amer. J. Clin Pathol 1967; 48(5):495-501.

Hoevers J, Holman P, Logan K, Hommel M, Ashford R, Snowden K. Restriction-fragment-length polymorphismanalysis of small-subunit rRNA genes of Blastocystis hominis isolates from geographically diverse human hosts. Parasitol Res 2000; 86(1):57-61.

Stensvold C, Suresh G, Tan K, Thompson R, Traub R, Viscogliosi E, et al. Terminology for Blastocystis subtypes-a consensus. Trends Parasitol 2007; 23(3):93-96.

Lee M, Stenzel D. A survey of Blastocystis in domestic chickens. Parasitol Res 1999; 85(2):109-117.

Abe N, Wu Z, Yoshikawa H. Zoonotic genotypes of Blastocystis hominis detected in cattle and pigs by PCR with diagnostic primers and restriction fragment length polymorphism analysis of the small subunit ribosomal RNA gene. Parasitol Res 2003; 90(2):124-128.

Yoshikawa H, Abe N, Wu Z. PCR-based identification of zoonotic isolates of Blastocystis from mammals and birds. Microbiology 2004; 150(5):1147-1151.

Noel C, Dufernez F, Gerbod D, Edgcomb V, Delgado-Viscogliosi P, Ho LC, et al. Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis. J Clin Microbiol 2005; 43(1):348-355.

Pintong A, Sunyanusin S, Prasertbun R, Mahittikorn A, Mori H, Changbunjong T, et al. Blastocystis subtype 5: Predominant subtype on pig farms, Thailand. Parasitol Int 2018; 67:824–828.

Phillips B, Zierdt CH. Blastocystis hominis pathogenic potencial in human patients and in gnotobiotes. Exp Parasitol 1976; 39:358-364.

Stenzel D, Boreham P, Mc Dougall R. Blastocystis hominis revisited. Clin Microbiol Rev 1996; 9(4):563-584.

Alfellani M, Stensvold C, Vidal-Lapiedra A, Onuoha E, Fagbenro A, Clark C. Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop 2013; 126(1):11-18.

Souppart L, Moussa H, Cian A, Sanciu G, Poirier P, El Alaoui H, et al. Subtype analysis of Blastocystis isolates from symptomatic patients in Egypt. Parasitol Res 2010; 106:505-511.

Abu-Madi M, Aly M, Behnke J, Clark C, Balkhy H. The distribution of Blastocystis subtypes in isolates from Qatar. Parasit Vectors 2015; 8:465.

Nagel R, Cuttell L, Stensvold C, Mills P, Bielefeldt-Ohmann H, Traub R. Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy. Intern Med J 2012; 42(11):1187-1195.

Zhu W, Tao W, Gong B, Yang H, Li Y, Song M, et al. First report of Blastocystis infections in cattle in China. Vet Parasitol 2017; 246(2017):38-42.

Yason J, Shyong K. Membrane Surface Features of Blastocystis Subtypes. Genes 2018; 9(8):417.

Moe K, Singh M, Howe J, Ho L, Tan S, Chen X, et al. Development of Blastocystis hominis cysts into vacuolar forms in vitro. Parasitol Res 1999; 85(2):103-108.

Lepczyńska M, Białkowska J, Dzika E, Piskorz-Ogórek K, Korycińska J. Blastocystis: how do specific diets and human gut microbiota affect its development and Pathogenicity? Eur J Clin Microbiol Infect Dis 2017; 31:1689-1696.

Nasirudeen A, Tan K, Singh M, Yap E. Programmed cell death in a human intestinal parasite, Blastocystis hominis. Parasitology 2001; 123(3):235-246.

Chandra S, Jeremiah S. Blastocystis: Taxonomy, biology and virulence. Tropical Parasitology 2013; 3(1):17-25.

Rajamanikam A, Govind S. Amoebic forms of Blastocystis spp. evidence for a pathogenic role. Parasit Vectors 2013; 6(1): 295.

Moosavi A, Haghighi A, Mojarad E, Zayeri F, Alebouyeh M, Khazan H, et al. Genetic variability of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Iran. Parasitol Res 2012; 111(6):2311-2315.

Andersen L, Stensvold C. Blastocystis in Health and Disease. Are we moving from a clinical to a public health perspective? J Clin Microbiol 2016; 54(3):524-528.

Nourrisson C, Scanzi J, Pereira B, NkoudMongo C, Wawrzyniak I, Cian A, et al. Blastocystis is associated with decreased of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One 2014; 9(11):e111868.

Scanlan P, Stensvold C, Rajilić-Stojanović M, Heilig H, De Vos W, O’Toole P, et al. The microbial eukaryote Blastocystisis a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol 2014; 90(1):326-330.

Chandramathi S, Govind Suresh K. Mahmood A, Kuppusamy. Urinary hyaluronidase activity in rats infected with Blastocystis hominis-evidence for invasion? Parasitol Res 2010; 106(6):1459-1463.

Wawrzyniak I, Texier C, Poirier P, Viscogliosi E, Tan K, Delbac F, et al. Characterization of two cysteine proteases secreted by Blastocystis ST7, a human intestinal parasite. Parasitol Int 2012; 61(3):437-442.

Long H, Handschack A, Konig W, Ambrosch A. Blastocystis hominis modulates immune responses and cytokine release in colonic epithelial cells. Parasitol Res 2001; 87(12):1029-1030.

Puthia M, Sio S, Lu J, Tan K. Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement and barrier function disruption in IEC-6 cells. Infect Immun 2006; 74(7):4114-4123.

Puthia M, Lu J, Tan K. Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kappaBdependent manner. Eukaryot Cell 2008; 7(3):435-443.

Mirza H, Tan K. Blastocystis exhibits inter- and intrasubtype variation in cysteine protease activity. Parasitol Res 2009; 104(2):355-361.

Nagel R, Traub R, Kwan M, Bielefeldt-Ohmann H. Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls. Parasites Vectors 2015; 8:453.

Nourrisson C, Wawrzyniak I, Cian A, Livrelli V, Viscogliosi E, Delbac F, et al. On Blastocystis secreted cysteine proteases: a legumain-activated cathepsin B increases paracellular permeability of intestinal Caco-2 cell monolayers. Parasitology 2016; 143(13):1713-1722.

Mirza H, Wu Z, Teo J, Tan K. Statin pleiotropy prevents rho kinase-mediated intestinal epithelial barrier compromise induced by Blastocystis cysteine proteases. Cell Microbiol 2012; 14(9):1474-1484.

Yakoob J, Abbas Z, Usman M, Sultana A, Islam M, Awan S, et al. Cytokine changes in colonic mucosa associated with Blastocystis spp. subtypes 1 and 3 in diarrhoea-predominant irritable bowel syndrome. Parasitology. 2014; 141(7):957-969. Doi: 10.1017/S003118201300173X.

Kumarasamy V, Rani U, Jayaloakshmi P, Samudi C, Devi N, Kumar S. Exacerbation of colon carcinogenesis by Blastocystis sp. PLoS ONE 2017; 12(8):e0183097.

Yamamoto-Furusho J, Torijano-Carrera E. Intestinal protozoa infections among patients with ulcerative colitis: Prevalence and impact on clinical disease course. Digestion 2010; 82(1):18-23.

Boorom K, Smith H, Nimri L, Viscogliosi E, Spanakos G, Parkar U, et al. Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasit Vectors 2008; 1:40.

Devera R, Blanco Y, Requena I, Velásquez V. Diagnóstico de Blastocystis hominis: bajo rendimiento de los métodos de concentración de formol-éter y sedimentación espontánea. Rev Biomed 2006; 17(3):231-233.

Figueroa M, Mora L, Silva H. Comparación de seis métodos coproscópicos para el diagnóstico del cromista Blastocystis spp. Saber 2017; 29:66-75.

Menounos P, Spanakos G, Tegos N, Vassalos C, Papadopoulou C, Vakalis N. Direct detection of Blastocystis sp. in human faecal samples and subtype assignment using single strand conformational polymorphism and sequencing. Mol Cell Probes 2008; 22(1):24-29.

Eymael D, Schuh G, Giacomelli Tavares R. Standarization of Blastocystis hominis diagnosis using different staining techniques. Rev Soc Bras Med Trop 2010; 43(3): 309-312.

Wettstein A, Borody T, Wee T, Torres M. Novel Intra-colonic Infusion of Three Antiparasite Agents for Resistant Blastocystis hominis Infections. Available in: http://www.e-learning.ueg.eu/documents-view.html? eprs%5Br%5D=9083 19/12/2012. Cited: 15 apr 2017.

Rodríguez C, Alcudia J, Martinez-Gonzalez J, Guadall A, Raposo B, Sanchez-Gomez S, et al. Statins normalize vascular lysyl oxidase down regulation induced by proatherogenic risk factors. Cardiovasc Res 2009; 83(3): 595-603.

Basyoni M, Fouad S, Amer M, Amer A, Ismail D. Atorvastatin: In-Vivo Synergy with Metronidazole as Anti-Blastocystis Therapy. Korean J Parasitol 2018; 56(2):105-112.